Ad is loading...
ACSCX
Price
$11.47
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VISVX
Price
$50.61
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

ACSCX vs VISVX

Header iconACSCX vs VISVX Comparison
Open Charts ACSCX vs VISVXBanner chart's image
American Century Small Cap Value A
Price$11.47
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$50.61
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ACSCX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACSCX vs. VISVX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACSCX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. ACSCX (5.75B). VISVX pays higher dividends than ACSCX: VISVX (1.90) vs ACSCX (0.70). ACSCX was incepted earlier than VISVX: ACSCX (25 years) vs VISVX (27 years). ACSCX is a more actively managed with annual turnover of: 44.00 vs. VISVX (16.00). ACSCX has a lower initial minimum investment than VISVX: ACSCX (2500) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 30.04 vs. ACSCX (27.31). VISVX return over 5 years is better than : 62.14 vs. ACSCX (54.32).
ACSCXVISVXACSCX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years27 years-
Gain YTD12.84217.71273%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets5.75B57.6B10%
Annual Yield % from dividends0.701.9037%
Returns for 1 year27.3130.0491%
Returns for 3 years-0.4816.92-3%
Returns for 5 years54.3262.1487%
Returns for 10 years21.76109.8320%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics